DK1717316T3 - Allelisk variant af interferon-lignende protein Zcyto21 - Google Patents

Allelisk variant af interferon-lignende protein Zcyto21

Info

Publication number
DK1717316T3
DK1717316T3 DK06012489T DK06012489T DK1717316T3 DK 1717316 T3 DK1717316 T3 DK 1717316T3 DK 06012489 T DK06012489 T DK 06012489T DK 06012489 T DK06012489 T DK 06012489T DK 1717316 T3 DK1717316 T3 DK 1717316T3
Authority
DK
Denmark
Prior art keywords
interferon
zcyto21
allelic variant
amino acid
protein
Prior art date
Application number
DK06012489T
Other languages
Danish (da)
English (en)
Inventor
Paul O Sheppard
Scott R Presnell
Brian A Fox
Teresa Gilbert
Francis J Grant
Betty A Haldeman
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26910034&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1717316(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of DK1717316T3 publication Critical patent/DK1717316T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
DK06012489T 2000-06-30 2001-06-29 Allelisk variant af interferon-lignende protein Zcyto21 DK1717316T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21544600P 2000-06-30 2000-06-30
US28542401P 2001-04-20 2001-04-20
PCT/US2001/021087 WO2002002627A2 (en) 2000-06-30 2001-06-29 Interferon-like protein zcyto21

Publications (1)

Publication Number Publication Date
DK1717316T3 true DK1717316T3 (da) 2008-12-08

Family

ID=26910034

Family Applications (2)

Application Number Title Priority Date Filing Date
DK06012489T DK1717316T3 (da) 2000-06-30 2001-06-29 Allelisk variant af interferon-lignende protein Zcyto21
DK01950827T DK1294888T3 (da) 2000-06-30 2001-06-29 Interferonlignende protein Zcyto21

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK01950827T DK1294888T3 (da) 2000-06-30 2001-06-29 Interferonlignende protein Zcyto21

Country Status (13)

Country Link
US (18) US6927040B2 (ru)
EP (4) EP1294888B1 (ru)
JP (1) JP4377126B2 (ru)
CN (1) CN100448993C (ru)
AT (2) ATE360696T1 (ru)
AU (1) AU2001271786A1 (ru)
BR (1) BR0112119A (ru)
CA (1) CA2413258C (ru)
DE (2) DE60128093T2 (ru)
DK (2) DK1717316T3 (ru)
ES (2) ES2311253T3 (ru)
RU (1) RU2292394C2 (ru)
WO (1) WO2002002627A2 (ru)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001271786A1 (en) * 2000-06-30 2002-01-14 Zymogenetics Inc. Interferon-like protein zcyto21
US7910313B2 (en) * 2001-04-20 2011-03-22 Zymogenetics, Inc. Cytokine protein family
US7038032B2 (en) 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
US20030104579A1 (en) * 2001-05-10 2003-06-05 Baum Peter R. Cytokine polypeptides
US6902930B2 (en) * 2001-08-29 2005-06-07 Vanderbilt University Human Mob-5 (IL-24) receptors and uses thereof
US7820793B2 (en) 2002-02-08 2010-10-26 University Of Medicine And Dentistry Of New Jersey IFN-λ polypeptides and compositions
AU2003225055B2 (en) 2002-04-19 2009-04-23 Bristol-Myers Squibb Company Cytokine receptor
EP1529108A2 (en) * 2002-08-07 2005-05-11 ZLB Behring GmbH Albumin-fused ciliary neurotrophic factor
AU2003286624B2 (en) * 2002-10-23 2008-11-13 Bristol-Myers Squibb Company Methods for treating viral infection using IL-28 and IL-29
PT2251353E (pt) 2003-08-07 2013-05-07 Zymogenetics Inc Preparações homogéneas de il-28 e il-29
AU2005231476B2 (en) * 2004-04-02 2011-09-01 Zymogenetics, Inc. Il-28 and il-29 cysteine mutants for treating viral infection
BRPI0513865A (pt) * 2004-07-29 2008-05-20 Zymogenetics Inc métodos para tratar cáncer, para inibir a progressão de cáncer, para retardar o começo de cáncer, para reduzir a severidade de cáncer, e para inibir pelo menos uma das condições ou sintomas de cáncer, do linfoma não-hodgkin, do mieloma múltiplo, e de tumores da cabeça e o pescoço
US20060178301A1 (en) * 2005-02-04 2006-08-10 Mathias Jurs Albumin-fused ciliary neurotrophic factor
US20070053933A1 (en) * 2005-07-20 2007-03-08 Sheppard Paul O IL28 and IL29 TRUNCATED CYSTEINE MUTANTS AND ANTIVIRAL METHODS OF USING SAME
CA2616004A1 (en) * 2005-07-20 2007-02-01 Zymogenetics, Inc. Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders
CA2625208A1 (en) * 2005-10-04 2007-04-12 Zymogenetics, Inc. Production and purification of il-29
TW200744634A (en) * 2006-02-21 2007-12-16 Wyeth Corp Methods of using antibodies against human IL-22
BRPI0821168B8 (pt) 2007-12-07 2021-05-25 Zymogenetics Inc anticorpo isolado que se liga ao il-21 humano, ou um fragmento deste, usos de dito anticorpo ou fragmento, e, hibridoma
JP5873717B2 (ja) 2008-04-04 2016-03-01 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア Ｉｌ−２８及び組成物を用いたワクチン及び免疫治療薬並びにその使用方法
JP2011522834A (ja) * 2008-06-05 2011-08-04 ザイモジェネティクス リミテッド ライアビリティ カンパニー Ｃ型肝炎の治療のためのペグ化ｉｉｉ型インターフェロンの使用
US20110263484A1 (en) * 2008-10-13 2011-10-27 Zymogenetics, Inc. Single chain fc type iii interferons and methods of using same
CN102858691B (zh) 2010-04-28 2015-09-23 株式会社村田制作所 具有阴离子控制的介电性质的钙钛矿材料、薄膜电容器器件及其制造方法
FR2975185A1 (fr) * 2011-05-12 2012-11-16 Univ Claude Bernard Lyon Procede de determination in vitro de la presence d'une sclerose en plaques
RU2549710C2 (ru) * 2012-06-29 2015-04-27 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) Способ очистки рекомбинантного белка интерфероноподобного фактора iii типа
CN102998450B (zh) * 2012-11-22 2014-10-15 北京正旦国际科技有限责任公司 一种食管癌免疫质谱检测试剂盒的制备方法
EP3092248B1 (en) 2014-01-08 2021-06-23 Prosit Sole Biotechnology (Beijing) Co. Ltd Fusion polypeptides and methods of use
US11311519B2 (en) 2014-05-01 2022-04-26 Eiger Biopharmaceuticals, Inc. Treatment of hepatitis delta virus infection
US10076512B2 (en) 2014-05-01 2018-09-18 Eiger Biopharmaceuticals, Inc. Treatment of hepatitis delta virus infection
HUE054068T2 (hu) 2015-04-21 2021-08-30 Eiger Biopharmaceuticals Inc Lonafarnibot és Ritonavirt tartalmazó gyógyszerkészítmények
WO2017143253A1 (en) 2016-02-19 2017-08-24 Eiger Biopharmaceuticals, Inc. Treatment of hepatitis delta virus infection with interferon lambda
AU2017336078B2 (en) * 2016-09-30 2022-07-21 The Board Of Trustees Of The Leland Stanford Junior University Variant type III interferons and synthekines

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3000213A1 (de) 1980-01-04 1981-07-09 Zahnfabrik Wienand Söhne & Co GmbH, 6072 Dreieich Verfahren zur herstellung eines vernetzten polymerisatz fuer dentalzwecke
PT72322B (en) * 1980-01-08 1982-09-23 Biogen Nv Process for preparation of recombinant dna molecules and of polipeptides similar to human interferon
AU560472B2 (en) 1981-08-25 1987-04-09 Celltech Limited Yeast expression vectors
US4579821A (en) 1981-11-23 1986-04-01 University Patents, Inc. Control of DNA sequence transcription
US4656134A (en) 1982-01-11 1987-04-07 Board Of Trustees Of Leland Stanford Jr. University Gene amplification in eukaryotic cells
US4486533A (en) 1982-09-02 1984-12-04 St. Louis University Filamentous fungi functional replicating extrachromosomal element
US4599311A (en) 1982-08-13 1986-07-08 Kawasaki Glenn H Glycolytic promotersfor regulated protein expression: protease inhibitor
US4977092A (en) 1985-06-26 1990-12-11 Amgen Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells
US4601978A (en) 1982-11-24 1986-07-22 The Regents Of The University Of California Mammalian metallothionein promoter system
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US5139936A (en) 1983-02-28 1992-08-18 Collaborative Research, Inc. Use of the GAL1 yeast promoter
US4661454A (en) 1983-02-28 1987-04-28 Collaborative Research, Inc. GAL1 yeast promoter linked to non galactokinase gene
US4870008A (en) 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
US4496778A (en) * 1983-10-03 1985-01-29 Exxon Research & Engineering Co. Process for the hydroxylation of olefins using molecular oxygen, an osmium containing catalyst, a copper Co-catalyst, and an aromatic amine based promoter
US4931373A (en) 1984-05-25 1990-06-05 Zymogenetics, Inc. Stable DNA constructs for expression of α-1 antitrypsin
US4766073A (en) 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
CA1280080C (en) 1984-12-06 1991-02-12 Jacques Oberto Promoters for the expression of foreign genes in yeast, plasmids comprising them, and uses thereof for the production of polypeptides
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
GR860984B (en) 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US4882279A (en) 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
US4935349A (en) 1986-01-17 1990-06-19 Zymogenetics, Inc. Expression of higher eucaryotic genes in aspergillus
GB8611832D0 (en) 1986-05-15 1986-06-25 Holland I B Polypeptide
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5063154A (en) 1987-06-24 1991-11-05 Whitehead Institute For Biomedical Research Pheromone - inducible yeast promoter
US4956288A (en) 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
US5037743A (en) 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
US5162228A (en) 1988-12-28 1992-11-10 Takeda Chemical Industries, Ltd. Gylceraldehyde-3-phosphate dehydrogenase gene and promoter
US5298418A (en) 1991-09-16 1994-03-29 Boyce Thompson Institute For Plant Research, Inc. Cell line isolated from larval midgut tissue of Trichoplusia ni
US5565332A (en) * 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
US5700638A (en) * 1993-08-26 1997-12-23 Washington University Cell death regulator
KR100289201B1 (ko) 1994-02-14 2001-05-02 엘. 데이예를 카렌. 조혈 단백질과 그것의 제조를 위한 재료 및 방법
US6451578B1 (en) * 1994-02-14 2002-09-17 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US5641655A (en) 1994-11-30 1997-06-24 Zymogenetics, Inc. Methods for producing thrombopoietin polypeptides using a mammalian tissue plasminogen activator secretory peptide
US5679715A (en) * 1995-06-07 1997-10-21 Harris; Richard Y. Method for treating multiple sclerosis
US5955349A (en) 1996-08-26 1999-09-21 Zymogenetics, Inc. Compositions and methods for producing heterologous polypeptides in Pichia methanolica
US5716808A (en) 1995-11-09 1998-02-10 Zymogenetics, Inc. Genetic engineering of pichia methanolica
US6025539A (en) * 1996-04-09 2000-02-15 Mayo Foundation For Medical Education And Research IL-5 transgenic mouse
TW517067B (en) * 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
CA2260293A1 (en) * 1996-07-09 1998-01-15 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
CN1230997A (zh) 1996-07-17 1999-10-06 津莫吉尼蒂克斯公司 甲醇毕赤酵母的转化
US5736383A (en) 1996-08-26 1998-04-07 Zymogenetics, Inc. Preparation of Pichia methanolica auxotrophic mutants
US5985614A (en) 1996-08-30 1999-11-16 Human Genome Sciences, Inc. Polynucleotides encoding interleukin-19
EP2314625B1 (en) 1996-12-03 2014-05-07 Amgen Fremont Inc. Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom
GB9702944D0 (en) * 1997-02-13 1997-04-02 Univ Manchester Reducing fibrosis
US5945511A (en) 1997-02-20 1999-08-31 Zymogenetics, Inc. Class II cytokine receptor
US5965704A (en) 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
AU2871899A (en) 1998-03-09 1999-09-27 Schering Corporation Human receptor proteins; related reagents and methods
US6143503A (en) * 1998-04-17 2000-11-07 Whitehead Institute For Biomedical Research Use of a ribozyme to join nucleic acids and peptides
CA2354536A1 (en) * 1998-12-18 2000-06-29 Schering Corporation Ribavirin-pegylated interferon alfa induction hcv combination therapy
EP1140142A2 (en) * 1998-12-22 2001-10-10 Schering Corporation Treatment of hepatitis c virus infections with interleukin-10
AU2001271786A1 (en) 2000-06-30 2002-01-14 Zymogenetics Inc. Interferon-like protein zcyto21
AU2002255478A1 (en) * 2001-01-10 2002-09-12 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
US7038032B2 (en) 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
US20030104579A1 (en) 2001-05-10 2003-06-05 Baum Peter R. Cytokine polypeptides
JP3939160B2 (ja) * 2001-05-25 2007-07-04 独立行政法人科学技術振興機構 腎臓における外来遺伝子発現方法
US7820793B2 (en) 2002-02-08 2010-10-26 University Of Medicine And Dentistry Of New Jersey IFN-λ polypeptides and compositions
AU2003286624B2 (en) * 2002-10-23 2008-11-13 Bristol-Myers Squibb Company Methods for treating viral infection using IL-28 and IL-29
PT2251353E (pt) 2003-08-07 2013-05-07 Zymogenetics Inc Preparações homogéneas de il-28 e il-29
AU2005231476B2 (en) 2004-04-02 2011-09-01 Zymogenetics, Inc. Il-28 and il-29 cysteine mutants for treating viral infection
CA2616004A1 (en) * 2005-07-20 2007-02-01 Zymogenetics, Inc. Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders
JP2011522834A (ja) 2008-06-05 2011-08-04 ザイモジェネティクス リミテッド ライアビリティ カンパニー Ｃ型肝炎の治療のためのペグ化ｉｉｉ型インターフェロンの使用
US20110263484A1 (en) 2008-10-13 2011-10-27 Zymogenetics, Inc. Single chain fc type iii interferons and methods of using same

Also Published As

Publication number Publication date
JP2004502419A (ja) 2004-01-29
EP1717316A1 (en) 2006-11-02
ATE360696T1 (de) 2007-05-15
RU2292394C2 (ru) 2007-01-27
ES2286128T3 (es) 2007-12-01
WO2002002627A3 (en) 2003-01-03
US20050014228A1 (en) 2005-01-20
US7485700B2 (en) 2009-02-03
EP1939293A2 (en) 2008-07-02
AU2001271786A1 (en) 2002-01-14
US20110054148A1 (en) 2011-03-03
EP1294888A2 (en) 2003-03-26
US20050106680A1 (en) 2005-05-19
ES2311253T3 (es) 2009-02-01
US7498154B2 (en) 2009-03-03
US20070049736A1 (en) 2007-03-01
US7655223B2 (en) 2010-02-02
US20120036590A1 (en) 2012-02-09
US7445913B2 (en) 2008-11-04
EP2132984A3 (en) 2010-11-03
US20020039763A1 (en) 2002-04-04
US6927040B2 (en) 2005-08-09
US20090069274A1 (en) 2009-03-12
DK1294888T3 (da) 2007-08-20
US7253261B2 (en) 2007-08-07
US7241870B2 (en) 2007-07-10
DE60128093D1 (de) 2007-06-06
EP1717316B1 (en) 2008-08-13
US20070043209A1 (en) 2007-02-22
JP4377126B2 (ja) 2009-12-02
DE60128093T2 (de) 2007-12-27
CN100448993C (zh) 2009-01-07
ATE404670T1 (de) 2008-08-15
EP1294888B1 (en) 2007-04-25
CN1443240A (zh) 2003-09-17
US20080102490A1 (en) 2008-05-01
US7252969B2 (en) 2007-08-07
BR0112119A (pt) 2003-05-06
US7919595B2 (en) 2011-04-05
US20080214788A1 (en) 2008-09-04
US20070042468A1 (en) 2007-02-22
CA2413258C (en) 2012-01-03
EP2132984A2 (en) 2009-12-16
CA2413258A1 (en) 2002-01-10
US20090326204A1 (en) 2009-12-31
US20100222266A1 (en) 2010-09-02
US20040146988A1 (en) 2004-07-29
US20050106682A1 (en) 2005-05-19
US7833520B2 (en) 2010-11-16
EP1939293A3 (en) 2008-07-09
US20070048841A1 (en) 2007-03-01
US20110172170A1 (en) 2011-07-14
WO2002002627A2 (en) 2002-01-10
US20120258458A1 (en) 2012-10-11
DE60135393D1 (de) 2008-09-25
RU2003103099A (ru) 2005-01-20

Similar Documents

Publication Publication Date Title
DK1717316T3 (da) Allelisk variant af interferon-lignende protein Zcyto21
DK0839196T3 (da) Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner
ATE388963T1 (de) Homogene herstellungen von il-29
ATE536406T1 (de) Neuartiger zytokin-zcytor17-ligand
ATE263778T1 (de) Niedrigallergene proteinvarianten
UA84666C2 (ru) ВЫДеЛЕНнЫЙ ПОЛИНУКЛЕОТИД, КОДИРУЮЩИЙ СЛИТОЙ ПРОТЕИН С ПЕСТИЦИДНОЙ АКТИВНОСТЬЮ, И ТРАНСГЕННАЯ КЛЕТКА-ХОЗЯИН
ATE378408T1 (de) Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren
DK1501936T3 (da) Familie af cytokin-proteiner
DE69432427D1 (de) Tomate xyloglukan endotransglykosylase
EP1557466A4 (en) TUMOR ANTIGEN PROTEIN AND USE THEREOF
DK0828004T3 (da) Proteindisulfidisomerase-gen afledt af stamme af methylotrof gær
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
SE0101519D0 (sv) Nucleic ACID
ATE278784T1 (de) Polypeptide
WO1999060117A3 (fr) Polypeptide prax-1